Hovione Names António Almeida and Marco Gil Co-CEOs as Jean-Luc Herbeaux Steps Down on 21 May After Three-Year Run — Both Incoming Executives Carry 19-Year Tenures and the Permanent CEO Search Is Already Open
Hovione, Portugal's flagship pharmaceutical contract-development-and-manufacturing group, will replace Jean-Luc Herbeaux with a two-person co-CEO bridge on 21 May 2026. António Almeida (CFO) and Marco Gil (SVP Sales & Marketing) take the top job jointly; both joined Hovione in 2007.
